LivingGLP1
Study S000653

Effect of NNC 90-1170 on Hypoglycaemic Counterregulation During Stepwise Hypoglycaemic Clamp in Type 2 Diabetic Subjects. A Double-blind, Placebo-controlled, Randomised, 2-period Cross-over Trial

Registration

Registration
NCT01509742
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
DOUBLE
Status
COMPLETED
Enrollment
19
Start
2001-04
Primary completion
2001-11
Lead sponsor
Novo Nordisk A/S
Conditions
Diabetes; Diabetes Mellitus, Type 2
Interventions
DRUG:liraglutide; DRUG:placebo
Results posted
FALSE

Registered primary outcomes

  • Area under the Curve (AUC) glucagon []

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.